TinyRx was a promising startup in the health care and mobile industries, providing an on-demand prescription delivery service in the Bay Area. Despite backing from prominent investors like Formation 8, GV, Middleland Capital, Winklevoss Capital, Great Oaks, StartX, Maiden Lane, Shu Duan, Carl Byers, and receiving a $5.00M Venture Round investment on 17 November 2015, the company faced challenges and shut down in May 2016. TinyRx's demise highlights the precarious nature of the startup ecosystem and the difficulties in achieving sustainable success, particularly in the healthcare and mobile sectors where regulatory hurdles and entrenched competition present formidable barriers to entry. This case underscores the importance of not only securing robust funding but also addressing operational and market challenges effectively to achieve long-term viability.